Switch to:
Repros Therapeutics Inc (NAS:RPRX)
Cash And Cash Equivalents
$60.65 Mil (As of Jun. 2014)

Repros Therapeutics Inc's quarterly cash and cash equivalents declined from Dec. 2013 ($75.81 Mil) to Mar. 2014 ($68.01 Mil) and declined from Mar. 2014 ($68.01 Mil) to Jun. 2014 ($60.65 Mil).

Repros Therapeutics Inc's annual cash and cash equivalents increased from Dec. 2011 ($4.57 Mil) to Dec. 2012 ($24.21 Mil) and increased from Dec. 2012 ($24.21 Mil) to Dec. 2013 ($75.81 Mil).


Cash and cash equivalents on banks book.

Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Repros Therapeutics Inc Annual Data

BS_CashAndCashEquivalents 0.742.171.141.7819.471.892.964.5724.2175.81

Repros Therapeutics Inc Quarterly Data

BS_CashAndCashEquivalents 12.119.9429.5824.2117.1587.7081.8375.8168.0160.65
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial